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Since the advent of use of phenothiazine
derivatives as "tranquilizing" drugs, physicians
have become aware of the occurrence of severe
contact dermatitis in response to administration
or handling of certain members of this chemical
group (1—3). In addition, clinical observations (4)
of the course of jaundice in patients taking oral
doses of tranquilizers of this group strongly
suggest that other side reactions, notably chlor-
promazine hepatitis, may well be allergic mani-
festations. Hepatitis, as well as agranulocytosis,
has been accompanied by skin reactions, and the
course of the liver sensitization and desensitiza-
tion, studied in a group of patients on a protracted
course of chlorpromazine therapy, seems to indi-
cate that a similar mechanism of drug sensitivity
is involved (5). A peculiar type of retinal toxicity,
which also seems to have an allergic basis, has
been reported with a phenothiazine drug (6).
In this paper we report on a patient in whom
skin sensitization developed after exposure to an
experimental phenothiazine derivative. Several
other analogues were examined by patch testing
in order to pinpoint the structural component to
which this patient was sensitive. Results seem
to indicate a rather specific structure-activity
relationship between chlorpromazine and its ana-
logues in causing this cross-reaction.
CASE HISTORY
A 31 year-old white woman laboratory worker
was engaged in handling a new phenothiazine
derivative, piperidylchlorophenothiazine hydro-
chloride (NP-207), during a pharmacological
experiment (7). After three weeks of daily contact
with the drug, the patient developed erythema
and pruritus of the hands that progressed to a
severe eczematous eruption covering the palmar
and dorsal surfaces of the fingers and hands up
to the wrists. The lesions persisted and gradually
improved during a ten-week period of treatment
and avoidance of contact with the drug.
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Nine months later the patient inadvertently
handled a number of phenothiazine drugs, in-
cluding NP-207, and immediate itching,
erythema, and scaling of the hands ensued and
persisted for one month (Fig. 1). After this rash
subsided, patch tests were performed on the
forearms, using solutions of NP-207, chlorpro-
mazine (Thorazine), prochlorperazine (Compa-
zine) and perphenazine (Trilafon), soaked in
small filter paper squares and applied to the skin
for 24 hours. All reactions were positive (Fig. 2).
One month later patch tests were repeated, using
the same compounds and many others in varying
concentrations (Table I). Again the tests were
repeated, applying the drugs for 48 hours, and
this time the test sites were exposed to two hours
of intense summer sunlight 48 hours after removal
of the patches.
After four testings, the patient became strongly
positive to promethazine (Phenergan), indicating
new sensitization to this agent. Two water-in-
soluble compounds, phenothiazine itself and
chlorphenothiazine, were applied in crystalline
form and elicted primary irritant reactions, which
were atypical in duration and character. Those
tests that had been negative did not become
positive after exposure to sunlight. Two control
subjects who were patch tested under the same
experimental conditions with the same drugs did
not develop positive reactions to any of them.
DISCUSSION AND COMMENT
Our studies of the skin reactions of this patient
to various phenothiazine derivatives indicate that
compounds containing a chlorine atom in the 2-
position of the phenothiazine nucleus elicit
positive skin reactions, while those without this
particular substituent lack skin sensitizing ability.
No reactions developed to compounds having a
hydrogen, and acetyl radical, or a grouping such
as—CF3 (in triflupromazine or Vesprin) in that
position. The chemistry of the side chain, the
feature by which the numerous chlorpromazine
analogues differ, did not modify the skin reaction.
Promazine and chlorpromazine with identical side
chains, differ only in the chlorine atom in question,
and in this pair of drugs only the latter produced
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FIG. 1. Scaling of hands following contact with a phenothiazine drug
FIG. 2. Reactions to patch tests using indicated drugs
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TABLE I
Drugs used for patch testing and reactions
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a skin reaction. It is probable that the side chain
need not be present, for the presence or absence
of activity seems to be a function of the nuclear
structure; this point merits further investigation
(13). Cross-sensitivity between various pheno-
thiazine derivatives, such as promethiazine and
chlorpromazine has been reported by Sidi,
Hincky, and Gervais (3). Other investigators
found no reactions with other phenothiazine
derivatives lacking the chlorine atom (Diparcol
and Parsidol) in patients who had positive patch
tests to chlorpromazine (8).
Intense pruritus and severe sunburn after ex-
posure to sunlight has been observed in patients
receiving large oral doses of chlorpromazine (9,
10). We were unable to demonstrate photo-cross
sensitivity between promethazine and chlorpro-
mazine or to any other phenothiazine derivatives
(3, 11). These phototoxic reactions probably
would not be elicited in our experimental work on
this patient, since at no time had she ingested any
of the drugs; photosensitivity to phenothiazine
derivatives is probably induced by ingestion, not
by external contact (10—12).
SUMMARY AND CONCLUSIONS
In a subject previously sensitized to a pheno-
thiazine derivative containing a chlorine atom in
the ring, positive skin reactions were elicited by
patch testing only with compounds having a
chlorine in the 2-position. Other atoms or radicals
gave negative reactions. The structure of the side
chain did not seem to be a critical factor in
causing contact (allergic) sensitization. Exposure
to strong mid-day sunlight did not bring out any
latent reactions and did not seem to affect the
severity of the skin reaction.
The experimental data suggest a possible struc
ture-activity relationship, which may be a factor
in the development of allergic skin reactions
following contact with certain phenothiazine de-
rivatives. Furthermore, sensitization of this type
may be related to other side reactions whose
manifestations strongly suggest an allergic basis
for this reaction.
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